Okapi Venture Partners: $250M+ LA VC Behind ServiceTitan, Honey, Science Exchange — And the Firm That Helps Science Startups Cross the Valley of Death

Walk into a room of Southern California founders and mention Okapi Venture Partners, and you'll see nods. This is the firm that held hands through the messy early days—when concepts were still half-formed, when the science was promising but the business model was a guess, when no one else would write the first check. That's by design.

Okapi Venture Partners, based in Long Beach, California, was founded in 2005 by a group of local business leaders who watched talented researchers and engineers struggle to cross what the life sciences world calls the Valley of Death—that brutal gap between a validated proof-of-concept and a fundable company. The firm's co-founders, including Marc Averitt and Sharon Stevenson (a DVM and PhD), built the fund with a specific conviction: that Southern California's research institutions were producing founders who deserved local capital, not just Bay Area attention.

Today, Okapi manages six funds with $250M+ in AUM and has backed over 100 companies. Their portfolio includes some genuinely impressive names: ServiceTitan, the field-service management SaaS that filed for a $500M IPO in 2024; Honey, the browser extension that Rakuten acquired for $4B; and Science Exchange, the research platform that connects labs with contracted services. These aren't just exits—they're proof points that Okapi can spot a category-defining company before the rest of the market catches on.

What makes Okapi different from coast-heavy VCs is the hands-on element. Partners like Jeff Bocan and John Waller aren't passive check-writers. They sit on boards, make introductions to enterprise customers, and—crucially—help founders navigate the operational chaos that comes after seed funding hits the bank. For science and research-backed startups, that guidance through the Valley of Death isn't nice to have. It's the whole point.

The firm operates at the earliest stages—primarily pre-seed and seed—when most institutional investors are still too big to play. For a founder in Long Beach, Pasadena, or San Diego trying to close a $1M round, Okapi isn't just an option. For many, they've been the only option in the room.

Okapi's thesis is straightforward and has remained consistent since 2005: invest in capital-efficient technology startups with a differentiated competitive advantage, targeting large and addressable markets, primarily in Southern California.

But the real texture of their thesis lives in the details. They look for what they call 'durable unfairness'—something about your technology, IP, team, or position that can't be easily replicated by a better-funded competitor within 18 months. For enterprise SaaS, this often means a proprietary data moat or a vertical-specific workflow that incumbents are too clumsy to copy. For life sciences, it means genuine scientific differentiation backed by published research or granted patents.

The firm explicitly avoids chasing categories du jour. While other SoCal funds were piling into crypto in 2021 or AI wrappers in 2023, Okapi held to their framework: is this company building something that solves a real pain point with a defensible solution, and can the founding team execute under pressure? If the answer to either is no, the deal moves on.

Geography is a real part of their thesis, not just a preference. Southern California's sprawl—from the Labs at UC Irvine to the engineering talent in the South Bay—produces companies with a particular character: scrappy, cost-conscious, and often closer to real customers than their Silicon Valley counterparts. Okapi knows this ecosystem intimately and has built their network to match.

On stage, they are flexible but biased toward seed and pre-seed. They have co-invested at Series A when the right opportunity arose, but the firm's identity is rooted in being the first institutional check, not a growth round participant. For founders seeking $750K to $3M to prove out a concept, Okapi is in their wheelhouse.

Okapi has kept a steady cadence despite a inhospitable fundraising environment. In 2023 and 2024, the firm continued deploying capital across enterprise SaaS, AI infrastructure, and climate-adjacent technologies—sectors where Southern California has genuine density.

Among recent investments are companies like Slingshot Aerospace (orbital tracking and space situational awareness), Figure.ai (humanoid robotics), and Jurny (AI-powered hotel operations software). These bets reflect a consistent pattern: Okapi gravitates toward companies where the underlying technology is hard to replicate, even if the market timing requires patience.

The firm has also been active in follow-on rounds for its strongest performers. When a portfolio company hits product-market fit and begins scaling, Okapi typically participates in the Series A to avoid dilution of their pro-rata. This is a meaningful signal: it means they're not afraid to put more capital behind winners.

Due diligence at Okapi runs thorough but not bureaucratic. Founders report a 2–4 week process from first meeting to term sheet when there's genuine interest. The Partners conduct reference calls, review technical architecture, and—in the case of deep tech or life sciences—often bring in domain experts to stress-test the science. This can feel rigorous, but it's also the kind of validation that opens doors to later-stage investors.

Okapi's portfolio spans roughly 100 companies across industries. The ones worth knowing cluster around a few themes: vertical SaaS, e-commerce infrastructure, scientific tooling, and emerging AI applications.

ServiceTitan is the crown jewel. Founded in Glendale, California, the company builds cloud-based software for field service businesses—HVAC, plumbing, electrical—and grew to $772M in ARR benchmarks before filing its S-1 in 2024. Okapi was an early backer, and the exit (whether through IPO or a later acquisition) will define the fund's legacy. The company's trajectory—vertical SaaS serving trades, high retention, 24% YoY growth—fits Okapi's thesis almost perfectly.

Honey needs no introduction in e-commerce circles. The browser extension that automatically applied coupon codes at checkout was acquired by Rakuten for $4B in 2020—a 100x return on early investment. The company was co-founded by George Li and Ryan S. Brown in Los Angeles, and it validated Okapi's ability to spot consumer utility before the market understood the moat.

Science Exchange addresses a less glamorous but genuinely important problem: the fragmented market for contract research services. Labs often need specialized equipment or expertise they don't have in-house, and Science Exchange provides the marketplace infrastructure to connect them with verified providers. It's the kind of B2B platform that Okapi has repeatedly demonstrated appetite for.

Among the current portfolio, several bear watching: Aline (workforce management for care facilities), Occuspace (foot traffic analytics using existing camera infrastructure), Specright (specification management for supply chains), and DeepCast (AI-powered weather and energy forecasting). Each sits in a vertical niche with clear data advantages.

On the robotics side, Figure.ai is building general-purpose humanoid robots. Okapi participated in the company's emergence, betting on a team with deep AI and mechanical engineering credentials. The company has moved quickly, signing partnerships with BMW and demonstrating real-world manipulation tasks.

Other names worth noting: Chargezoom (B2B payments infrastructure for SaaS), Daasity (data automation for e-commerce brands), DepoDirect (dental lab logistics), GoodHood (neighborhood commerce platform), and Trellis (legal tech for class action settlements). The diversity reflects Okapi's view that the best investments often come from founders with direct industry experience, not necessarily the loudest pitch decks.

First and foremost: founders who know their market better than anyone in the room. Okapi's Partners have sat through thousands of pitches, and the ones that break through are the ones where the founder can answer every question about their customer, their competitive landscape, and their unit economics with precision. Not bravado—specificity.

On metrics, Okapi is realistic about seed-stage companies. They don't expect ARR benchmarks at pre-seed, but they do want to see early traction signals: revenue, active users, a clear path to monetization, and evidence that customers are staying. A cohort retention curve that tells a good story goes further than a slide deck with a hockey-stick projection built on thin air.

Product differentiation is non-negotiable. Whether it's a granted patent, proprietary data, a viral distribution mechanism, or a workflow that's genuinely faster or cheaper than the alternative—something has to be hard to copy. Okapi will stress-test this in due diligence, often bringing in technical advisors to assess whether your moat holds under scrutiny.

The team composition matters too. Okapi has a stated preference for founders with deep domain expertise and complementary skill sets. A solo founder with a brilliant technical insight will get a meeting; but if they can't articulate the business model, the sales motion, or the hiring plan, the conversation ends quickly. The best OKAPI companies typically have at least two co-founders covering product and go-to-market.

Finally, they want to see capital efficiency. The firm's identity was forged in an era before infinite venture capital, and it shows. They back companies that can stretch a $1M seed round to meaningful milestones—often product-market fit or early revenue—without needing an immediate bridge. Founders who burn fast and raise fast are not the right fit for this fund.

Okapi's website lists a submission form, but founders who have gone through the process will tell you the same thing: a warm introduction dramatically improves your odds. The firm maintains an active relationship with Southern California's accelerator ecosystem—particularly Expert DOJO in Santa Monica—and with a network of angel investors and attorneys who co-refer deals regularly.

If you don't have a warm connection, the cold outreach path is not closed—but it's a longer one. Your deck needs to communicate exactly why Okapi, specifically, should care. Mentioning your Southern California roots, the specific problem you're solving, and why you believe Okapi's network is uniquely relevant to your stage helps. Generic outreach that looks like a mass-send gets filtered.

The best preparation for an Okapi meeting is knowing your numbers cold. They will ask about burn rate, runway, customer acquisition cost, lifetime value, and the logic behind your projections. Having a financial model that's grounded in real data—not aspirational market sizing—signals that you're ready for institutional capital. Many founders work with a fractional CFO to stress-test their financial narrative before approaching Okapi.

Follow-through matters. After an initial meeting, send a brief note with any updates—new customers signed, product milestones hit, or key hires made. Okapi's process isn't fast (2–4 weeks to term sheet is typical), and maintaining a low-friction communication cadence keeps you on their radar for future rounds even if the current one doesn't close.

A final note: Okapi has been known to re-engage founders who weren't ready at first contact. If your metrics were too early, or your team composition was incomplete, the firm has circled back 12–18 months later when the picture was clearer. Building a relationship before you need money is a legitimate strategy here.

While Okapi invests in early-stage companies, they expect founders to have a solid handle on their financials. This includes understanding your burn rate, runway, unit economics, and path to profitability—or the logic behind your next fundraise.

Many first-time founders underestimate the importance of financial preparedness when raising capital. Investors want to see that you understand your business's financial mechanics and have realistic expectations for how you'll use the capital you raise.

Working with a fractional CFO can significantly improve your chances of securing funding. Professional financial guidance helps you build accurate projections, prepare investor-ready financials, and confidently answer due diligence questions.

Our team has helped numerous companies raise venture capital and would be happy to discuss how we can support your fundraising efforts. From pitch deck financials to comprehensive financial models, we ensure you're prepared for the investment process.

Financial projections should be realistic and grounded in evidence. Okapi will scrutinize your assumptions and challenge your projections. Be prepared to explain the basis for your forecasts and demonstrate that you've considered various scenarios.

Understanding your key performance indicators (KPIs) is essential when pitching to Okapi. The firm will want to see that you track the metrics that matter most to your business and can explain trends in your performance.

Whether you're preparing to pitch Okapi or other top VCs, having professional financials can set you apart from the competition. Our team has helped companies raise understands what investors look for in financial presentations.

Exploring other venture capital firms? Our comprehensive collection of VC firm reviews covers hundreds of investors across all stages and sectors.

Each review provides detailed information about investment criteria, portfolio companies, and tips for securing funding. Whether you're looking for seed-stage investors or growth equity firms, you'll find valuable insights in our VC firm guides.

Finding the right investor for your startup is crucial to your success. Take the time to research potential investors and understand their investment thesis before reaching out.

Our guides cover major venture capital firms as well as emerging managers that may be a better fit for your company's specific needs and stage.